LQDA Q3 2022 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-0.4% YoY

Gross Profit

$2M76.6% margin

Operating Income

-$9M-279.0% margin

Net Income

-$9M-287.3% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

-19.2%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$133M

Total Liabilities

$38M

Stockholders' Equity

$95M

Cash & Equivalents

$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-0.4%
Gross Profit	$2M	$2M	+5.9%
Operating Income	-$9M	-$7M	-24.7%
Net Income	-$9M	-$7M	-24.9%